Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 144, Issue -, Pages 112276
Publisher
Elsevier BV
Online
2021-10-02
DOI
10.1016/j.biopha.2021.112276
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020
- (2021) Kathy Leung et al. Eurosurveillance
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- (2021) Robert L. Gottlieb et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2
- (2021) Tianling Ou et al. PLoS Pathogens
- Patients with uncomplicated COVID-19 have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic
- (2021) Karen B Jacobson et al. CLINICAL INFECTIOUS DISEASES
- In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
- (2021) Linda Petrone et al. JOURNAL OF INFECTION
- A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19
- (2021) Maren de Vries et al. JOURNAL OF VIROLOGY
- Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein
- (2021) Houriiyah Tegally et al. NATURE
- Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7
- (2021) Pengfei Wang et al. NATURE
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2
- (2021) Llipsy Santiago et al. Biology-Basel
- Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial
- (2021) Keivan Ranjbar et al. BMC INFECTIOUS DISEASES
- A two-arm, randomized, controlled, multi-centric, open-label phase-2 study to evaluate the efficacy and safety of Itolizumab in moderate to severe ARDS patients due to COVID-19
- (2021) Suresh Kumar et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial
- (2021) Reaz Mahmud et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Neutralizing Antibody Therapeutics for COVID-19
- (2021) Aeron C. Hurt et al. Viruses-Basel
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
- (2021) Prasanna Jagannathan et al. Nature Communications
- Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
- (2021) Jean-Sélim Driouich et al. Nature Communications
- SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
- (2021) Bingyu Yan et al. Science Immunology
- Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
- (2021) Matthew Geriak et al. Infectious Diseases and Therapy
- Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit
- (2021) Matthew D Hall et al. JOURNAL OF INFECTIOUS DISEASES
- Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
- (2021) Delphine Planas et al. NATURE
- Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
- (2021) Michael Dougan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- (2021) John McCoy et al. Frontiers in Medicine
- Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
- (2021) Paul C Cremer et al. Lancet Rheumatology
- The broad spectrum antiviral ivermectin targets the host nuclear transport importin α/β1 heterodimer
- (2020) Sundy N.Y. Yang et al. ANTIVIRAL RESEARCH
- Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells
- (2020) Feng Qu et al. INVESTIGATIONAL NEW DRUGS
- Cytomegalovirus, Epstein‐Barr Virus and Human Herpesvirus 6 Infections in Patients with Myalgic Еncephalomyelitis/Chronic Fatigue Syndrome
- (2020) Evelina Shikova et al. JOURNAL OF MEDICAL VIROLOGY
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
- (2020) Timothy P. Sheahan et al. Nature Communications
- Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
- (2020) Jesús Villar et al. Lancet Respiratory Medicine
- Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)
- (2020) M. Montopoli et al. ANNALS OF ONCOLOGY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
- (2020) Chuan Qin et al. CLINICAL INFECTIOUS DISEASES
- What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy
- (2020) Andy Goren et al. Dermatologic Therapy
- Androgen sensitivity gateway to COVID ‐19 disease severity
- (2020) Carlos Gustavo Wambier et al. DRUG DEVELOPMENT RESEARCH
- SARS ‐CoV‐2 receptor ACE 2 and TMPRSS 2 are primarily expressed in bronchial transient secretory cells
- (2020) Soeren Lukassen et al. EMBO JOURNAL
- Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19
- (2020) D. Praveen et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Musculoskeletal Consequences of COVID-19
- (2020) Nathaniel P. Disser et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – the “Gabrin sign”
- (2020) Carlos Gustavo Wambier et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Testing COVID-19 therapies to prevent progression of mild disease
- (2020) Marc Lipsitch et al. LANCET INFECTIOUS DISEASES
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir
- (2020) Wanchao Yin et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- (2020) Andy Goren et al. Journal of Cosmetic Dermatology
- Racial Variations in COVID‐19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti‐Androgens a Potential Treatment for COVID‐19?
- (2020) John McCoy et al. Journal of Cosmetic Dermatology
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
- (2020) Daniel Wrapp et al. CELL
- Interleukin-6 in Rheumatoid Arthritis
- (2020) Pandolfi Franco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19
- (2020) Ling Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Inhibition of SARS-CoV-2 by type I and type III interferons
- (2020) Ulrike Felgenhauer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase
- (2020) Leili Zhang et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Inhibition of human adenovirus replication by the importin α/β1 nuclear import inhibitor ivermectin
- (2020) Cason R. King et al. JOURNAL OF VIROLOGY
- A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
- (2020) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A molecular pore spans the double membrane of the coronavirus replication organelle
- (2020) Georg Wolff et al. SCIENCE
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial
- (2020) J. P. Desilles et al. Trials
- Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial
- (2020) Maryam Edalatifard et al. EUROPEAN RESPIRATORY JOURNAL
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
- (2020) Christoph D. Spinner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
- (2020) Robert L. Hoffman et al. JOURNAL OF MEDICINAL CHEMISTRY
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Serious Ivermectin Toxicity and Human ABCB1 Nonsense Mutations
- (2020) Eloise Baudou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia
- (2020) Francesco Salton et al. Open Forum Infectious Diseases
- Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
- (2020) Alexandra C. Walls et al. CELL
- High‐dose methylprednisolone in nonintubated patients with severe COVID‐19 pneumonia
- (2020) Aikaterini Papamanoli et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
- (2020) Wesley H. Self et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization
- (2020) Eric Salazar et al. JOURNAL OF CLINICAL INVESTIGATION
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
- (2020) Ventura A. Simonovich et al. NEW ENGLAND JOURNAL OF MEDICINE
- To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps
- (2019) Sebastian Boeltz et al. CELL DEATH AND DIFFERENTIATION
- Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy
- (2019) Lauren Bowen Reoma et al. ANNALS OF NEUROLOGY
- Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
- (2019) Mart Toots et al. Science Translational Medicine
- JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
- (2018) Leandro Ladislau et al. BRAIN
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
- (2018) Steven J. Forrester et al. PHYSIOLOGICAL REVIEWS
- RNA Dependent RNA Polymerases: Insights from Structure, Function and Evolution
- (2018) Sangita Venkataraman et al. Viruses-Basel
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
- (2018) Maria L. Agostini et al. mBio
- Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
- (2018) Erica Ollmann Saphire et al. CELL
- Influenza A Virus Infection Induces Muscle Wasting via IL-6 Regulation of the E3 Ubiquitin Ligase Atrogin-1
- (2018) Kathryn A. Radigan et al. JOURNAL OF IMMUNOLOGY
- Macrophage Extracellular Traps: A Scoping Review
- (2017) Ryan S. Doster et al. Journal of Innate Immunity
- β-D- N 4 -Hydroxycytidine Is a Potent Anti-alphavirus Compound That Induces a High Level of Mutations in the Viral Genome
- (2017) Nadya Urakova et al. JOURNAL OF VIROLOGY
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
- (2017) Timothy P. Sheahan et al. Science Translational Medicine
- IL-6 ameliorates acute lung injury in influenza virus infection
- (2017) Mei-Lin Yang et al. Scientific Reports
- T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab
- (2017) Usha Bughani et al. PLoS One
- Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea
- (2016) Johan van Griensven et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib in Patients with Refractory Rheumatoid Arthritis
- (2016) Mark C. Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Family-wide Structural Analysis of Human Numb-Associated Protein Kinases
- (2016) Fiona J. Sorrell et al. STRUCTURE
- Compound 21, a selective agonist of angiotensin AT2receptors, prevents endothelial inflammation and leukocyte adhesionin vitroandin vivo
- (2015) Amanda K Sampson et al. BRITISH JOURNAL OF PHARMACOLOGY
- Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae
- (2015) J. I. Meyers et al. JOURNAL OF EXPERIMENTAL BIOLOGY
- Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
- (2015) Li-Fong Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Guarding the frontiers: the biology of type III interferons
- (2015) Andreas Wack et al. NATURE IMMUNOLOGY
- Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
- (2015) Olivier Reynard et al. Viruses-Basel
- Losartan improves measures of activity, inflammation, and oxidative stress in older mice
- (2014) Chung-Hao Lin et al. EXPERIMENTAL GERONTOLOGY
- The pharmacokinetics, pharmacodynamics, and safety of baricitinib, an oral JAK 1/2 inhibitor, in healthy volunteers
- (2014) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study
- (2014) D.S. Krupashankar et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Immunological and histological evaluation of clinical samples from psoriasis patients treated with anti-CD6 itolizumab
- (2014) Lazaro E Aira et al. mAbs
- The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke
- (2014) Jason P. Joseph et al. NEUROPHARMACOLOGY
- Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
- (2014) Kris V. Kowdley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Androgen Regulation of the TMPRSS2 Gene and the Effect of a SNP in an Androgen Response Element
- (2013) Liesbeth Clinckemalie et al. MOLECULAR ENDOCRINOLOGY
- Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
- (2013) Rowan Wathes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
- (2013) Everett Clinton Smith et al. PLoS Pathogens
- Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
- (2012) Kylie M. Wagstaff et al. BIOCHEMICAL JOURNAL
- Synthesis and antiviral activity of a series of 1′-substituted 4-aza-7,9-dideazaadenosine C-nucleosides
- (2012) Aesop Cho et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Effects of Hydroxychloroquine on Immune Activation and Disease Progression Among HIV-Infected Patients Not Receiving Antiretroviral Therapy
- (2012) Nicholas I. Paton et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort
- (2012) R Willis et al. LUPUS
- Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection
- (2011) I. F. Hung et al. CLINICAL INFECTIOUS DISEASES
- Hydroxychloroquine: From Malaria to Autoimmunity
- (2011) Ilan Ben-Zvi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- CD6 attenuates early and late signaling events, setting thresholds for T-cell activation
- (2011) Marta I. Oliveira et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- SARS-CoV 9b Protein Diffuses into Nucleus, Undergoes Active Crm1 Mediated Nucleocytoplasmic Export and Triggers Apoptosis When Retained in the Nucleus
- (2011) Kulbhushan Sharma et al. PLoS One
- Neutrophil Elastase Enhances Sputum Solubilization in Cystic Fibrosis Patients Receiving DNase Therapy
- (2011) Venizelos Papayannopoulos et al. PLoS One
- CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction
- (2010) P. Nair et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
- (2010) J. S. Fridman et al. JOURNAL OF IMMUNOLOGY
- Interferon-Lambda: A New Addition to an Old Family
- (2010) Raymond P. Donnelly et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Ivermectin disrupts the function of the excretory-secretory apparatus in microfilariae of Brugia malayi
- (2010) Y. Moreno et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence
- (2009) J. Chia et al. JOURNAL OF CLINICAL PATHOLOGY
- An Ivermectin-Sensitive Glutamate-Gated Chloride Channel from the Parasitic Nematode Haemonchus contortus
- (2009) S. McCavera et al. MOLECULAR PHARMACOLOGY
- Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps
- (2009) A. B. Guimaraes-Costa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
- (2008) Yoshiyuki Ohsugi et al. EXPERT OPINION ON BIOLOGICAL THERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now